Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2007-02-16
2010-06-29
Silverman, Eric E. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S489000
Reexamination Certificate
active
07744924
ABSTRACT:
A method of forming a multi-particulate dosage form using rotary granulation is described in which polyethylene oxide is employed as s binder in a rotary granulation process. A multi-particulate oral dosage form comprises a plurality of pellets, the pellets comprising a core having disposed thereon a core composition layer. The core composition layer comprises venlafaxine and a binder, wherein the binder comprises a polyethylene oxide. In other embodiments, the binder comprises a 1:2:1 bis (butyl methacrylate-co-(2-dimethylaminoethyl)methacrylate-co-methyl methacrylate.
REFERENCES:
patent: 4535186 (1985-08-01), Husbands et al.
patent: 4582705 (1986-04-01), Primes et al.
patent: 5026560 (1991-06-01), Makino et al.
patent: 5792471 (1998-08-01), Curatolo
patent: 5912013 (1999-06-01), Rudnic et al.
patent: 6274171 (2001-08-01), Sherman et al.
patent: 6310101 (2001-10-01), Rudolph et al.
patent: 6403120 (2002-06-01), Sherman et al.
patent: 6500454 (2002-12-01), Percel et al.
patent: 6572890 (2003-06-01), Faour et al.
patent: 6723348 (2004-04-01), Faham et al.
patent: 6863901 (2005-03-01), Hirsh et al.
patent: 2003/0190352 (2003-10-01), Escoi et al.
patent: 2 304 727 (1997-03-01), None
A. Kramer, S. Turk, F. Vrecer, International Journal of Pharmaceutics 256 (2003) 43-52, “Statistical Optimisation Diclofenac Sustained Release Pellets Coated with Polymethacrylic Films”.
Murali K. Vuppala, Dilip M. Parikh and Hitesh R. Bhagat, Drug Development and Industrial Pharmacy, 23(7), 687-694 (1997) Research Paper, “Application of Powder-Layering Technology and Film Coating for Manufacture of Sustained-release Pellets Using a Rotary Fluid Bed Processor”.
Nantharat Pearnchob, Roland Bodmeier, European Journal of Pharmaceutics and Biopharmaceutics 56 (2003) 363-369, “Dry Polymer Powder Coating and Comparison with Conventional Liquid-Based Coatings for Eudragit RS, Ethylcellulose and Shellac”.
Angela Y. Lin, Nouman A. Muhammad, David Pope and Larry L. Augsburger, Pharmaceutical Development and Technology, vol. 8, No. 3, pp. 277-287, 2003, “A Study of the Effects of Curing and Storage Conditions on Controlled Release Diphenhydramine HC1 Pellets Coated with Eudragit NE30D”.
Nuttanan Sinchaipanid, Padungkwan Chitropas and Ampol Mitrevej, Pharmaceutical Development and Technology vol. 9, No. 2, pp. 163-170, 2004, Research Article, “Influences of Layering on Theophylline Pellet Characteristics”.
Martin Wesseling, Roland Bodmeier, European Journal of Pharmaceutics and Biopharmaceutics 47 (1999) 33-38, Research Paper, “Drug Release From Beads Coated With an Aqueous Colloidal Ethylcellulose Dispersion, Aquacoat, or an Organic Ethylcellulose Solution”.
Isaac Ghebre-Sellassie and Axel Knoch, “Pelletization Techniques”, Encyclopedia of Pharmaceutical Technology, Copyright 2002 pp. 2067-2080.
Shun Li, Kenneth M. Feld, and Chana R. Kowarski, “The Effect of Polymer Coating Systems on the Preparation, Tableting, and Dissolution Properties of Sustained Release Drug Pellets”, in Drug Dev. and Indus. Pharm., 23(7), pp. 623-627 (1997).
Non Pareil Seeds (NEU Pellets) as per DuPharm, pp. 1-4, Oct. 14, 2003.
Principles of Polymerization-Third Edition; George Odian, Ed.; John Wiley & Sons, Inc., New York; pp. 20-23; (1991).
Dispensing of Medication—Eighth Edition; John E. Hoover, Ed.; Mack Publishing Company; “Pharmaceutical Factors”; pp. 61-63; (1976).
“Polyethylene Glycol” in Handbook of Pharmaceutical Excipients; Rowe and Sheskey eds.; Pharmaceutical Press; Fourth Edition; pp. 454-459; (2003).
“Polyethylene Oxide” in Handbook of Pharmaceutical Excipients; Rowe and Sheskey eds.; Pharmaceutical Press; Fourth Edition; pp. 460-461; (2003).
Cai, et al.; “Analysis of Interfacial Phenomena of Aqueous Solutions of Polyethylene Oxide and Polyethylene Glycol Flowing in Hydrophilic and Hydrophobic Capillary Viscometers”; Journal of Colloid and Interface Science; 276; pp. 174-181; (2004) Abstract only, 1 page.
Actavis Group HF
Cantor & Colburn LLP
Silverman Eric E.
LandOfFree
Venlafaxine formulations and methods of preparing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Venlafaxine formulations and methods of preparing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Venlafaxine formulations and methods of preparing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4162989